Craft

Enovis

Stock Price

$50.2

2024-05-24

Market Capitalization

$2.8 B

2024-05-24

Revenue

$1.7 B

FY, 2023

Enovis Summary

Company Summary

Overview
Enovis (formerly known as Colfax) is a medical technology company providing clinically differentiated solutions. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes products under the DJO brand to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment offers a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company caters to orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals.
Type
Public
Status
Active
Founded
1995
HQ
Wilmington, DE, US | view all locations
Website
https://enovis.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Matthew L. Trerotola

    Matthew L. Trerotola, Chair and Chief Executive Officer

  • Ben Berry

    Ben Berry, Chief Financial Officer

  • Brady R. Shirley

    Brady R. Shirley, President, Chief Operating Officer & Director

    • Patricia Lang

      Patricia Lang, Senior Vice President and Chief Human Resources Officer

    Operating MetricsView all

    Countries (Production Facilities)

    11
    8.3%

    FY, 2023

    Production Facilities

    18
    5.9%

    FY, 2023

    Business Segments

    2

    FY, 2023

    LocationsView all

    23 locations detected

    • Wilmington, DE HQ

      United States

      2711 Centerville Road, Suite 400

    • Asheboro, NC

      United States

      718 Industrial Park Ave

    • Austin, TX

      United States

      9800 Metric Blvd

    • Carlsbad, CA

      United States

      5919 Sea Otter Place, Suite 200

    • Fort Worth, TX

      United States

      3300 Eagle Pkwy, Suite 150

    • Lewisville, TX

      United States

      2900 Lake Vista Drive, Suite 200

    and 17 others

    Enovis Financials

    Summary Financials

    Revenue (Q1, 2024)
    $516.3M
    Gross profit (Q1, 2024)
    $297.9M
    Net income (Q1, 2024)
    ($71.8M)
    Cash (Q1, 2024)
    $66.3M
    EBIT (Q1, 2024)
    ($35.0M)
    Enterprise value
    $4.1B

    Footer menu